Cargando…
Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents
Ebola virus (EBOV) infections cause lethal hemorrhagic fever in humans, resulting in up to 90% mortality. EBOV outbreaks are sporadic and unpredictable in nature; therefore, a vaccine that is able to provide durable immunity is needed to protect those who are at risk of exposure to the virus. This s...
Autores principales: | Wong, Gary, Audet, Jonathan, Fernando, Lisa, Fausther-Bovendo, Hugues, Alimonti, Judie B., Kobinger, Gary P., Qiu, Xiangguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115511/ https://www.ncbi.nlm.nih.gov/pubmed/25173474 http://dx.doi.org/10.1016/j.vaccine.2014.08.028 |
Ejemplares similares
-
Transient Liver Damage and Hemolysis Are Associated With an Inhibition of Ebola Virus Glycoprotein-Specific Antibody Response and Lymphopenia
por: Fausther-Bovendo, Hugues, et al.
Publicado: (2021) -
Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb
por: Qiu, Xiangguo, et al.
Publicado: (2013) -
Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012) -
Role of Key Infectivity Parameters in the Transmission of Ebola Virus Makona in Macaques
por: de La Vega, Marc Antoine, et al.
Publicado: (2021) -
NK Cells Accumulate in Infected Tissues and Contribute to Pathogenicity of Ebola Virus in Mice
por: Fausther-Bovendo, H., et al.
Publicado: (2019)